Literature DB >> 7152196

Suppression of tumorigenicity in interspecific reconstituted cells and cybrids.

M Koura, H Isaka, M C Yoshida, M Tosu, T Sekiguchi.   

Abstract

The effect of cytoplasms on the expression of tumorigenicity was examined in interspecific reconstituted cells and cytoplasmic hybrids (cybrids) formed by fusions between karyoplasts (or intact cells) from highly tumorigenic mouse melanoma B16 cells and cytoplasts from non-tumorigenic, hypoxanthine-guanine phosphoribosyl-transferase (HGPRT)-deficient and chloramphenicol (CAP)-resistant rat myoblastic cells, L6TG X CAPr. The reconstituted clones and cybrid clones isolated in the double selection medium, HAT and CAP, acquired CAP-resistance, and each showed unique morphology and cellular arrangement. Tumorigenicity was suppressed in all the reconstituted clones and cybrid clones examined at an early stage after their isolation, but re-appeared in some clones after prolonged cultivation of the cells.

Entities:  

Mesh:

Year:  1982        PMID: 7152196

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  9 in total

1.  Cytoplasmic mediation of malignancy.

Authors:  B A Israel; W I Schaeffer
Journal:  In Vitro Cell Dev Biol       Date:  1988-05

2.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

3.  Cytoplasmic suppression of malignancy.

Authors:  B A Israel; W I Schaeffer
Journal:  In Vitro Cell Dev Biol       Date:  1987-09

4.  Cancer stem cell theory and the warburg effect, two sides of the same coin?

Authors:  Nicola Pacini; Fabio Borziani
Journal:  Int J Mol Sci       Date:  2014-05-19       Impact factor: 5.923

Review 5.  Tumorigenesis as a process of gradual loss of original cell identity and gain of properties of neural precursor/progenitor cells.

Authors:  Ying Cao
Journal:  Cell Biosci       Date:  2017-11-07       Impact factor: 7.133

Review 6.  Cancer Etiology: A Metabolic Disease Originating from Life's Major Evolutionary Transition?

Authors:  B Poljsak; V Kovac; R Dahmane; T Levec; A Starc
Journal:  Oxid Med Cell Longev       Date:  2019-10-08       Impact factor: 6.543

Review 7.  The Role of Mitochondrial miRNAs in the Development of Radon-Induced Lung Cancer.

Authors:  Assiya Kussainova; Olga Bulgakova; Akmaral Aripova; Zumama Khalid; Rakhmetkazhi Bersimbaev; Alberto Izzotti
Journal:  Biomedicines       Date:  2022-02-11

8.  Cancer as a mitochondrial metabolic disease.

Authors:  Thomas N Seyfried
Journal:  Front Cell Dev Biol       Date:  2015-07-07

Review 9.  Cancer as a metabolic disease: implications for novel therapeutics.

Authors:  Thomas N Seyfried; Roberto E Flores; Angela M Poff; Dominic P D'Agostino
Journal:  Carcinogenesis       Date:  2013-12-16       Impact factor: 4.944

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.